Clinical Trial Update: Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing QVM149 to a free triple combination in asthma has completed, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• QVM149 (Indacaterol acetate / glycopyrronium bromide / mometasone furoate)
• Salmeterol/Fluticasone/Tiotropium free triple combination

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2020-10-14